Production of SV40-derived vectors
- PMID: 20516174
- DOI: 10.1101/pdb.prot5436
Production of SV40-derived vectors
Abstract
Recombinant simian virus 40 (rSV40)-derived vectors are particularly useful for gene delivery to bone marrow progenitor cells and their differentiated derivatives, certain types of epithelial cells (e.g., hepatocytes), and central nervous system neurons and microglia. They integrate rapidly into cellular DNA to provide long-term gene expression in vitro and in vivo in both resting and dividing cells. Here we describe a protocol for production and purification of these vectors. These procedures require only packaging cells (e.g., COS-7) and circular vector genome DNA. Amplification involves repeated infection of packaging cells with vector produced by transfection. Cotransfection is not required in any step. Viruses are purified by centrifugation using discontinuous sucrose or cesium chloride (CsCl) gradients and resulting vectors are replication-incompetent and contain no detectable wild-type SV40 revertants. These approaches are simple, give reproducible results, and may be used to generate vectors that are deleted only for large T antigen (Tag), or for all SV40-coding sequences capable of carrying up to 5 kb of foreign DNA. These vectors are best applied to long-term expression of proteins normally encoded by mammalian cells or by viruses that infect mammalian cells, or of untranslated RNAs (e.g., RNA interference). The preparative approaches described facilitate application of these vectors and allow almost any laboratory to exploit their strengths for diverse gene delivery applications.
Similar articles
-
Titering replication-defective rSV40 vectors.Cold Spring Harb Protoc. 2010 Jun;2010(6):pdb.prot5437. doi: 10.1101/pdb.prot5437. Cold Spring Harb Protoc. 2010. PMID: 20516175
-
Factors influencing the production of recombinant SV40 vectors.Mol Ther. 2004 Oct;10(4):780-91. doi: 10.1016/j.ymthe.2004.06.1014. Mol Ther. 2004. PMID: 15451462
-
SV40-based gene therapy vectors: turning an adversary into a friend.Curr Opin Mol Ther. 2000 Oct;2(5):570-8. Curr Opin Mol Ther. 2000. PMID: 11249759 Review.
-
Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors.Gene Ther. 2000 May;7(10):886-95. doi: 10.1038/sj.gt.3301159. Gene Ther. 2000. PMID: 10845727
-
Gene therapy using SV40-derived vectors: what does the future hold?J Cell Physiol. 1999 Dec;181(3):375-84. doi: 10.1002/(SICI)1097-4652(199912)181:3<375::AID-JCP1>3.0.CO;2-8. J Cell Physiol. 1999. PMID: 10528223 Review.
Cited by
-
Cre Recombinase Mediates the Removal of Bacterial Backbone to Efficiently Generate rSV40.Mol Ther Methods Clin Dev. 2018 Feb 27;9:225-233. doi: 10.1016/j.omtm.2018.02.010. eCollection 2018 Jun 15. Mol Ther Methods Clin Dev. 2018. PMID: 29766030 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources